A carregar...
Eltrombopag for use in children with immune thrombocytopenia
Eltrombopag is currently the only US Food and Drug Administration–approved thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia (ITP) in children. This oral, once-per-day therapy has shown favorable efficacy and adverse effect profiles in children. Two multicenter, do...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5858473/ https://ncbi.nlm.nih.gov/pubmed/29487060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017010660 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|